| Literature DB >> 35567311 |
Angélica Graça1, Ana Margarida Martins1, Helena Margarida Ribeiro1, Joana Marques Marto1.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enforced the use of hand sanitation and of personal protective equipment, such as masks and visors, especially by health-care professionals, but also by the general public. However, frequent hand sanitation and the prolonged and continuous use of personal protective equipment are responsible for constant frictional and pressure forces on skin causing lesions, the most reported being acne, facial itching, dryness, and rash. Thus, it is important to find measures to prevent skin lesions, in order to improve the quality of life of health-care professionals and of the general public. This article gathers the current information regarding measures to prevent human to human transmission of COVID-19, reviews the most common skin lesions caused by the use of hand sanitizers and different types of personal protective equipment, and the possible preventive measures that can be used on a daily basis to minimize the risk of developing skin-related pathologies. Daily skin care routines and the incorporation of a dressing between the skin and the personal protective equipment to serve as a protective barrier are some of the applied measures. Moisturizers and dressings improve the skin's ability to respond to constant aggressions. Lastly, the need for additional studies to evaluate the lubrication properties of different types of dressings is discussed. The understanding of what kind of dressing is more suitable to prevent pressure injuries is crucial to promote healthy skin and wellbeing during pandemic times.Entities:
Keywords: coronavirus disease 2019; dressings; hand sanitation; personal protective equipment; skin care; skin lesions
Mesh:
Year: 2022 PMID: 35567311 PMCID: PMC9347758 DOI: 10.1111/1346-8138.16431
Source DB: PubMed Journal: J Dermatol ISSN: 0385-2407 Impact factor: 3.468
Specifications of alcohol‐based hand sanitizers available in the European and US markets used by the general public and HCP
| Brand | Manufacturer | Active components | Dosage Form | Users | Mechanism of action | Interference with the skin barrier |
|---|---|---|---|---|---|---|
| Alcogel H® | Prodene Klint (division of Mediprop) | Isopropanol | Gel | GP | Denaturation of proteins and lipids in membranes of microorganisms; reduction of the surface tension of the cell membrane | Removes significant amounts of lipids from the stratum corneum, which may impair the skin barrier function |
| Assanis Pro Gel® | Blue Skin | Ethanol, Isopropanol, Quaternary ammonium | Gel | GP | ||
| Clinogel® | Viatris | Isopropanol, Triclosan | Gel | HCP/GP | ||
| Dermalcool® | Deb Arma (division of Neoderma) | Ethanol, Isopropanol, Triclosan | Gel | GP | ||
| Manugel Plus® | Anios | Ethanol, Isopropanol, Phenoxyethanol | Gel | HCP/GP | ||
| Manugel Plus NPC® | Anios | Ethanol, Isopropanol, Phenoxyethanol | Gel | HCP/GP | ||
| Manurub® | Stéridine (division of Hydenet) | Phenoxyethanol, n‐propanol, Isopropanol, Ethanol | Liquid | HCP | ||
| Manurub Gel | Stéridine (division of Hydenet) | Phenoxyethanol, Amino‐methylpropanol, Ethanol | Gel | HCP/GP | ||
| Purell® | Gojo | Ethanol, Isopropanol | Gel | GP | ||
| Purell 85® | Gojo | Ethanol, Isopropanol | Gel | HCP/GP | ||
| Spitacid® | Ecolab Health Care (supplied by Paragerm) | Ethanol, Isopropanol, Benzyl alcohol | Liquid | HCP/GP | ||
| Spitagel® | Ecolab Health Care (supplied by Paragerm) | Ethanol, Isopropanol, Hydrogen peroxide | Gel | GP | ||
| Sterillium® | Bode Chemie (supplied by Rivadis) | Isopropanol, n‐propanol, Mecetronium ethylsulphate | Liquid | GP | ||
| Sterillium Gel® | Bode Chemie (supplied by Rivadis) | Ethanol | Gel | HCP/GP |
Abbreviations: GP, general public; HCP, health‐care professional.
Chemical groups of commonly used alcohol‐free hand sanitizers
| Chemical group | Examples of active ingredients | Users | Action mechanism | Concentration (%) | Interference with the skin barrier |
|---|---|---|---|---|---|
| Chlorine compounds | Sodium hypochlorite | GP | Halogenation/oxidation of cellular proteins; cytotoxic mechanism: cellular energy metabolism impairment, DNA synthesis reduction, progressive mitochondrial dehydrogenase dysfunction, and subsequent cell death | 0.01–4 | Cytotoxic to keratocytes, compromise skin barrier integrity; oxidizing agents damage healthy tissue and its components (e.g., human SC, collagen, fibroblasts, immunological cells such as macrophages) |
| Chlorine dioxide | GP | ||||
| Chloramine‐t‐trihydrate | GP | ||||
| Calcium hypochlorite | GP | ||||
| Sodium dichloroisocyanurate | GP | ||||
| Iodine compounds | Povidone‐iodine (polyvinylpyrrolidone with iodine) | GP | Penetrate the pathogen cell membrane, irreversibly binds tyrosine residues in proteins, interfere with hydrogen bonds in some amino acids residues and nucleic acids, oxidize sulfhydryl groups, react with unsaturated bonds in lipids; oxidizing agents that cause the precipitation of bacterial proteins and nucleic acids; block the respiratory electron transport chain through electrolytic reactions with enzymes | 5–10 | Corrosive; inhibits fibroblast aggregation, delaying wound healing, induction of epithelial cell death, and inhibition of leukocyte migration; high concentrations may cause necrosis, low concentrations cause apoptosis |
| QAC | Benzalkonium chlorides | HCP/GP | Lower surface tension; enzymatic inactivation; denaturation of essential microbial cytoplasmic proteins | 0.02–0.04 | Promote keratinization due to keratinocytes death in the epidermis; strongly hydrophilic QAC bind to the negatively charged extracellular matrix on the cell surface, inducing strong subacute cytotoxicity |
| Benzyl dimethyl octyl ammonium chloride | GP | ||||
| Didecyl dimethyl ammonium chloride | GP | ||||
| Peroxygens | Hydrogen peroxide | GP | Inactivate contaminating spores; produce hydroxyl radicals (OH·) that damage cell components, leading to the breakdown of biofilms, cell membranes, and cell walls | 0.5–3 | Diffuses through the SC into the epidermis, breaking down into oxygen and water and converted to OH·, which can overwhelm the skin's antioxidant system and drive oxidative stress‐triggered apoptosis or necrosis of sensitive cells; corrosive damage, lipid peroxidation, cytotoxicity in fibroblasts and keratinocytes |
| Peracetic acid | GP | ||||
| Phenols | Triclosan | GP | Penetrate cytoplasmic membrane bilayer; alter the cell membrane and the synthesis of RNA, fatty acids and proteins | 0.2–0.5 | Topical application of triclosan damages the skin barrier, inducing cellular and immune responses, including modulation of cytokines expression by keratinocytes |
| Biguanide | Chlorhexidine | GP | Ionic interaction; passively diffuses through bacterial cell membranes altering their permeability; inhibits the enzymes of the periplasmic space; high concentrations cause precipitation of proteins and nucleic acids | 0.5–4 | Increases cell permeability contributing to cell components leakage; decreases cell proliferation by suppressing DNA synthesis; alters cytoskeletal organization, changing cellular configuration; disrupts protein synthesis |
Abbreviations: GP, general public; HCP, health‐care professional; QAC, Quaternary ammonium compounds; SC, stratum corneum.
Summary of the main skin lesions caused by hand sanitizers, their causes and prevention
| Skin pathology | ||
|---|---|---|
| Contact dermatitis | Allergic dermatitis | |
| Clinical features | Burning, redness, stinging, soreness | Pruritus, redness |
| Pathogenesis | Direct toxic effect by chemicals or physical agents on the epidermal keratinocytes, resulting in SC disruption and repair impairment, triggers the innate immune system | Delayed T‐cell‐mediated hypersensitivity reaction to external chemicals or physical agents occurring in susceptible individuals |
| Causes | Detergents, hot water rinse, iodophors, chlorhexidine; chloroxylenol, triclosan, quaternary ammonium compounds; alcohol‐based products | Fragrance, preservatives, isopropanol, n‐propanol |
| Solution | Application of moisturizing skin care products; alcohol‐based hand sanitizers containing humectants | Use fragrance‐free products, less harmful preservatives |
| Affected population | HCP/GP | HCP/GP |
Abbreviations: GP, general public; HCP, health‐care professional; SC, stratum corneum.
Reported skin lesions resulting from the use of PPE and respective treatments and preventions
| Personal protective equipment | Users | Protection mechanisms | Skin lesions | Interference with skin barrier | Treatment/Prevention |
|---|---|---|---|---|---|
| Masks and respirators | GP/HCP | Prevention of inhalation of infectious particles | Nasal bridge scarring, cheeks facial itching, dry skin and rash, discoloration and ulceration on the nose bridge, jaw, cheeks and ears, tissue ischemia and hypoxia,“maskne” |
Differences in the skin temperature, transepidermal water loss, sebum content, skin pH, skin pores size and elasticity within hours. Tissue deformation, cell damage and death, inflammation, edema, interstitial pressure and ischemia |
Mild cases: Skin care with moisturizers. Severe cases: Antibacterial cleansers; creams with bacterial/fungal/ anti‐inflammatory agents; glucocorticoid creams; dressings as an interface between the PPE and skin |
| Medical gloves | GP/HCP | Protection against anticipated contact with blood, infectious materials | Contact and allergic dermatitis | Shearing forces and physical pressure associated with recurrent application and removal of gloves, compromising blood supply, possibly leading to ischemia, cellular death and tissue necrosis | Moisturization before donning occlusive gloves with hand cream or mild steroid cream; nonfractional drying |
| Gowns, coveralls and aprons | HCP | Protection against the transmission of microorganisms in blood and fluids of potentially infected patients. | Acne in the chest and back, allergic dermatitis |
Device‐related pressure injuries due to friction between the clothing edge and the skin. Temperature increase altering skin pH levels | Skin care with moisturizers |
| Goggles and face shiels | HCP | Protection of eyes from exposure to plashes, sprays, splatter and respiratory secretions | Indentations, ecchymosis, maceration, abrasion, erosion | Mechanical damage to the skin trough pressure forces leading to ischemia | Cream with bacterial/fungal/ anti‐inflammatory agents; glucocorticoid creams; dressings as an interface between the PPE and skin |
Abbreviations: GP, general public; HCP, health‐care professional; PPE, personal protective equipment.
FIGURE 1Examples of the most reported skin lesions caused the use of masks, gloves, goggles/face shields, gowns and coveralls by health‐care professionals. (a) Redness and irritation caused by alcohol‐based hand sanitizers; (b) dry skin caused by glove usage; (c) “maskne”; (d) scaring on the nose bridge due to N95 masks; (e) indentation on the forehead caused by face shield usage; (f) indentation under the eye from goggles usage; (g) ulceration behind the ear caused by mask elastic ear loops; (h,i) acne on the chest and back, respectively, caused by coverall usage
FIGURE 2Summary of possible outcomes of personal protective equipment (PPE) use in terms of skin health. The arrows represent hypothetical decisions one might make when using a PPE, which may or may not result in skin damage